Efficacy and Safety of Indacaterol Acetate Delivered Via the Concept1 Inhalation Device in Children Greater or Equal to 6 and Less Than 12 Years of Age With Asthma

NCT02892019 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

79

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Indacaterol acetate 75 μg
DRUG: Indacaterol acetate 150 μg

Sponsor

Novartis Pharmaceuticals